Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

495 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fluorescent in situ hybridization on isolated tumor cell nuclei: a sensitive method for 1p and 19q deletion analysis in paraffin-embedded oligodendroglial tumor specimens.
Gelpi E, Ambros IM, Birner P, Luegmayr A, Drlicek M, Fischer I, Kleinert R, Maier H, Huemer M, Gatterbauer B, Anton J, Rössler K, Budka H, Ambros PF, Hainfellner JA. Gelpi E, et al. Mod Pathol. 2003 Jul;16(7):708-15. doi: 10.1097/01.MP.0000076981.90281.BF. Mod Pathol. 2003. PMID: 12861068
The prion protein in human neuromuscular diseases.
Kovács GG, Kalev O, Gelpi E, Haberler C, Wanschitz J, Strohschneider M, Molnár MJ, László L, Budka H. Kovács GG, et al. Among authors: gelpi e. J Pathol. 2004 Nov;204(3):241-7. doi: 10.1002/path.1633. J Pathol. 2004. PMID: 15476279
No prognostic impact of survivin expression in glioblastoma.
Preusser M, Gelpi E, Matej R, Marosi C, Dieckmann K, Rössler K, Budka H, Hainfellner JA. Preusser M, et al. Among authors: gelpi e. Acta Neuropathol. 2005 May;109(5):534-8. doi: 10.1007/s00401-005-0992-x. Epub 2005 Apr 20. Acta Neuropathol. 2005. PMID: 15843906
Histopathologic assessment of hot-spot microvessel density and vascular patterns in glioblastoma: Poor observer agreement limits clinical utility as prognostic factors: a translational research project of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
Preusser M, Heinzl H, Gelpi E, Schonegger K, Haberler C, Birner P, Marosi C, Hegi M, Gorlia T, Hainfellner JA; European Organization for Research and Treatment of Cancer Brain Tumor Group. Preusser M, et al. Among authors: gelpi e. Cancer. 2006 Jul 1;107(1):162-70. doi: 10.1002/cncr.21973. Cancer. 2006. PMID: 16721804 Free article.
Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series.
Kovacs GG, Milenkovic I, Wöhrer A, Höftberger R, Gelpi E, Haberler C, Hönigschnabl S, Reiner-Concin A, Heinzl H, Jungwirth S, Krampla W, Fischer P, Budka H. Kovacs GG, et al. Among authors: gelpi e. Acta Neuropathol. 2013 Sep;126(3):365-84. doi: 10.1007/s00401-013-1157-y. Epub 2013 Jul 31. Acta Neuropathol. 2013. PMID: 23900711
α-Synuclein antibody 5G4 identifies manifest and prodromal Parkinson's disease in colonic mucosa.
Skorvanek M, Gelpi E, Mechirova E, Ladomirjakova Z, Han V, Lesko N, Feketeova E, Repkova B, Urbancikova Z, Vargova A, Spisak P, Ribeiro Ventosa J, Kudela F, Kulcsarova K, Babinska S, Toth S, Gombosova L, Zakuciova M, Veseliny E, Trebuna F, Lutz MI, Gdovinova Z, Kovacs GG; PARCAS studygroup. Skorvanek M, et al. Among authors: gelpi e. Mov Disord. 2018 Aug;33(8):1366-1368. doi: 10.1002/mds.27380. Mov Disord. 2018. PMID: 30230627 No abstract available.
How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy.
Grimm MJ, Respondek G, Stamelou M, Arzberger T, Ferguson L, Gelpi E, Giese A, Grossman M, Irwin DJ, Pantelyat A, Rajput A, Roeber S, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Colosimo C, van Eimeren T, Kassubek J, Levin J, Meissner WG, Nilsson C, Oertel WH, Piot I, Poewe W, Wenning GK, Boxer A, Golbe LI, Josephs KA, Litvan I, Morris HR, Whitwell JL, Compta Y, Corvol JC, Lang AE, Rowe JB, Höglinger GU; Movement Disorder Society-endorsed PSP Study Group. Grimm MJ, et al. Among authors: gelpi e. Mov Disord. 2019 Aug;34(8):1228-1232. doi: 10.1002/mds.27666. Epub 2019 Mar 18. Mov Disord. 2019. PMID: 30884545 Free PMC article.
Validation of the movement disorder society criteria for the diagnosis of 4-repeat tauopathies.
Respondek G, Grimm MJ, Piot I, Arzberger T, Compta Y, Englund E, Ferguson LW, Gelpi E, Roeber S, Giese A, Grossman M, Irwin DJ, Meissner WG, Nilsson C, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Höglinger GU; Movement Disorder Society-Endorsed Progressive Supranuclear Palsy Study Group. Respondek G, et al. Among authors: gelpi e. Mov Disord. 2020 Jan;35(1):171-176. doi: 10.1002/mds.27872. Epub 2019 Sep 30. Mov Disord. 2020. PMID: 31571273 Free PMC article.
495 results